Global Health Limited Schedules Investor Meetings on September 8, 2026
Global Health Limited will meet with investors and analysts, including Matthews International Capital Management and Baillie Gifford, on September 8, 2026. The meetings will be held in person in Gurugram. No unpublished price sensitive information will be shared.
This is a standard disclosure regarding upcoming investor interactions and does not involve any new material information that would significantly affect the company's stock price or business operations.
The announcement is a routine intimation of investor meetings and does not contain any specific financial results or strategic decisions that would impact the company's valuation.
Global Health Limited (MEDANTA) has announced a schedule for meetings with investors and analysts, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The management will engage in one-to-one meetings with Matthews International Capital Management and Baillie Gifford on September 8, 2026. These meetings will take place in Gurugram and will be conducted in person. The company has stated that no Unpublished Price Sensitive Information (UPSI) is expected to be shared during these interactions. The schedule is subject to change due to unforeseen circumstances.
A plain-language summary of a public exchange filing by Global Health Limited. Read the original for the full detail.